Plus Therapeutics, Inc. (NASDAQ:PSTV) Q2 2024 Earnings Call Transcript August 14, 2024
Plus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.53.
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus’ Call. Before we begin, we want to advise you that over the course of the call, including any question-and-answer session, forward-looking statements will be made regarding events, trends, business prospects and financial...
